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RESEARCH ARTICLE Open Access
Exogenous 17-β estradiol administration
blunts progression of established angioten-
sin II-induced abdominal aortic aneurysms
in female ovariectomized mice
Sean E. Thatcher1, Xuan Zhang1, Shannon Woody1, Yu Wang1, Yasir Alsiraj1, Richard Charnigo2,
Alan Daugherty3,4 and Lisa A. Cassis1*
Abstract
Background: Abdominal aortic aneurysms (AAAs) occur predominately in males. However, AAAs in females
have rapid growth rates and rupture at smaller sizes. Mechanisms contributing to AAA progression in females are
undefined. We defined effects of ovariectomy, with and without 17-β estradiol (E2), on progression of established
angiotensin II (AngII)-induced AAAs in female mice.
Methods: We used neonatal testosterone exposures at 1 day of age to promote susceptibility to AngII-induced
AAAs in adult female Ldlr−/− mice. Females were infused with AngII for 28 days to induce AAAs, and then stratified
into groups that were sham, ovariectomized (Ovx, vehicle), or Ovx with E2 administration for 2 months of continued
AngII infusions. Aortic lumen diameters were quantified by ultrasound and analyzed by linear mixed model, and
maximal AAA diameters were analyzed by one-way ANOVA. Atherosclerosis was quantified en face in the aortic
arch. AAA tissue sections were analyzed for cellular composition. We quantified effects of E2 on abdominal aortic
smooth muscle cell (SMC) growth, α-actin and transforming growth factor-beta (TGF-β) production, and wound
healing.
Results: Serum E2 concentrations were increased significantly by E2. Aortic lumen diameters increased over time in
sham-operated and Ovx (vehicle) females, but not in Ovx females administered E2. At day 70, E2 administration
decreased significantly aortic lumen diameters compared to Ovx vehicle and sham-operated females. Compared
to Ovx females (vehicle), maximal AAA diameters were reduced significantly by E2. AAA tissue sections from Ovx
females administered E2 exhibited significant increases in α-actin and decreases in neutrophils compared to Ovx
females administered vehicle. In abdominal aortic SMCs, E2 resulted in a concentration-dependent increase in
α-actin, elevated TGF-β, and more rapid wound healing. E2 administration to Ovx females also significantly reduced
atherosclerotic lesions compared to sham-operated females. This effect was accompanied by significant reductions
in serum cholesterol concentrations.
Conclusions: E2 administration to Ovx females abolished progressive growth and decreased severity of
AngII-induced AAAs. These effects were accompanied by increased SMC α-actin, elevated TGF-β, and reduced
neutrophils. Similarly, E2 administration reduced AngII-induced atherosclerosis. These results suggest that loss
of E2 in post-menopausal females may contribute to progressive growth of AAAs.
Keywords: Angiotensin, Abdominal aortic aneurysms, Estrogen, Atherosclerosis, Transforming growth factor-beta
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Background
Abdominal aortic aneurysms (AAA) occur more frequently
in males than females, making the male gender the largest
non-modifiable risk factor for this insidious vascular dis-
ease [1, 2]. Similarly, male hypercholesterolemic mice ex-
hibit a two- to threefold higher prevalence of angiotensin II
(AngII)-induced AAA formation compared to females [3].
Results from our laboratory demonstrated that androgen is
the primary mediator of increased incidence of AngII-
induced AAA formation in male mice [4]. In addition,
adult female mice administered testosterone exhibited
increased incidence of AngII-induced AAAs [4]. Strikingly,
even a single administration of testosterone to neonatal
female mice was sufficient to promote an increased inci-
dence of AngII-induced AAAs at adulthood [5].
Clinical diagnosis of AAAs is most common by ultra-
sound quantification of aortic diameter. The majority of
studies examining AAA development in experimental
models have focused on initiating events contributing to
AAA formation. Unfortunately, there are no medical
therapies that have been proven to halt or reduce AAA
progression. A lack of information on mechanisms con-
tributing to experimental AAA progression most likely
has contributed to the dearth of therapies capable of
blunting progressive AAA growth. Moreover, few studies
have incorporated interventions after an AAA is estab-
lished and monitored effects of interventions on AAA
progression. This is significant because as AAA size
increases, so does the propensity for aneurysm rupture
which results in >80 % mortality [6–10].
Despite a higher prevalence of AAAs in males than
females (both in humans and in AngII-induced AAAs in
mice), the growth rate of established AAAs in females is
enhanced compared to males. Also, AAAs rupture at
smaller sizes in females [7, 9, 11, 12]. As most females with
an AAA are post-menopausal, this raises the question
whether the absence of ovarian-derived female hormones
in postmenopausal females contributes to a more aggres-
sive AAA growth rate. We demonstrated recently that
castration of male mice blunts the progression of estab-
lished AngII-induced AAAs [13]. However, partly due to a
low AAA incidence in adult female hypercholesterolemic
mice infused with AngII, it is unclear whether female sex
hormones influence AAA progression. We hypothesized
that female sex hormones (specifically E2) reduce the pro-
gression of established AngII-induced AAAs in adult fe-
male hypercholesterolemic mice. To study the progression
of AngII-induced AAAs in female mice, we administered
neonatal females a single dose of testosterone at 1 day of
age to increase their adult susceptibility to AAA for-
mation [5]. In these adult females exhibiting an estab-
lished AngII-induced AAA, we stratified mice to groups
that underwent sham surgery, or ovariectomy, with and
without E2 administration and followed AAA progression.
Methods
Mice
Female low-density lipoprotein-receptor-deficient (Ldlr−/−)
mice on a C57BL/6 background (13 times backcrossed,
stock #002207, Jackson Laboratory mice; 2–3 months of
age; total of 57 females) were bred in-house. To promote
adult AAA susceptibility, female mice were administered
(subcutaneously) 1 dose of testosterone (400 μg per
mouse) at 1 day of age. At 2 months of age, females were
fed a Western diet (Teklad, TD88137, 42 % kcal from
fat, 0.2 % cholesterol) and were infused with AngII
(1000 ng/kg/min; Bachem) by micro-osmotic pump
(Model 1004, Alzet Inc.) for 28 days. The Western
diet was continued through study duration. Ultrasound
was used as described below to quantify suprarenal aortic
lumen diameters in anesthetized mice (isoflurane, 2–3 %).
Mice (total of 44) exhibiting an increase (33 %) in aortic
lumen diameter compared to baseline (day 0) were classi-
fied as having an AAA. Mice were stratified to three
groups: sham surgery (n = 14), ovariectomized (Ovx) plus
vehicle (corn oil; n = 14), or Ovx plus E2 (36 μg/mL,
equivalent to a dose of 1.2 μg/kg/day via silastic tubing;
n = 16; Sigma) [14]. We stratified AAAs by aortic lumen
diameter to each group such that mean diameters of the
three groups (at day 28 of AngII infusions) were similar.
After surgery (sham or Ovx), mice were implanted
with minipumps containing AngII or silastic implants
containing vehicle or E2, with replacement of minipumps
and silastic implants every 28 days for two more months.
During the final 2 months of AngII infusions, aortic rup-
tures occurred in each group (sham, n = 2; Ovx + vehicle,
n = 3; Ovx + E2, n = 4). Therefore, the numbers com-
pleting the study were sham-operated (n = 12), Ovx,
vehicle (n = 11), and Ovx, E2 (n = 12). All procedures
follow the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were approved
by the University of Kentucky Institutional Animal Care
and Use Committee.
Blood cell content
Whole blood (20 μL) was placed in EDTA-coated tubes
(cat#20.1278.100, Sarstedt) and placed on a rotator until
all samples were collected. Samples were analyzed using
a Hemavet 950FS (ERBA Diagnostics Inc.), and results
were averaged (K or 1000 cells per microliter)(K/μL).
Ovariectomy
Surgeries were performed on anesthetized female mice
(2–3 % isoflurane) administered pre- (30 min prior) and
post-analgesic (48 h after surgery; flunixin; 2.5 mg/kg).
Mice were shaved on each flank and a depilatory cream
was used to remove hair, followed by sterilizing with
povidone-iodine/ethanol (three times). An incision was
made through the skin to visualize the abdominal wall,
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where an additional incision was made (1–3 mm) to locate
the ovaries. Fallopian tubes were collapsed using a hemostat
and the ovaries were removed. The wound site was then
cauterized using a high-temperature fine-tip loop and the
hemostat was released. The wound site was monitored for
bleeding, and the abdominal wall was sutured (absorbable,
Vicryl 5.0) and skin was stapled (Autoclip stapler). The site
was then treated with povidone-iodine, and mice were
allowed to recover in a clean cage on a heating pad.
Quantification of AAAs by ultrasound and ex vivo
measurements
Ultrasound was performed using a 55-MHz probe with a
Vevo 2100 high-resolution imaging system (VisualSonics,
Inc.) to quantify suprarenal aortic lumen diameters [15].
Mice were anesthetized (2–3 % isoflurane), and abdominal
hair was removed by shaving and applying a hair depila-
tory cream (Nair, Inc.). Ultrasound was used to quantify
aortic lumen diameters once/week during months 2 and 3
of AngII infusions by two independent observers blinded
to the experimental design. To quantify AAA maximal
external diameters at study endpoint, aortas were removed,
placed in fixative (10 % formalin), cleaned of extraneous
tissue, and mounted on a black wax background. Images
were taken with a Nikon SMZ800 dissecting microscope
with camera, and a ruler was included in the frame.
Image analysis was performed using Nikon Elements
Version 3.2.
Characterization of AAA tissue sections
Immersion-fixed AAAs were incubated in 30 % sucrose,
placed on wax, and pinned. Serial sections of AAAs
(at 10 μm intervals) covering a distance of 4–8 mm
were placed on each slide, which was stored at −20 °C. For
immunostaining, tissue sections were incubated at 60 °C
for 1–2 h to remove water, then cleared with 100 % xylene
for 5 min, followed by alcohol dehydration at 100, 95, and
75 %, and then distilled water (2 min each). Redusol
(0.05 % chromic acid) was incubated with AAA sections
for 2 min at 40 °C. Sections were washed with automation
buffer (GeneTex, Inc.) and incubated in hydrogen peroxide
(1 % in methanol) to extinguish endogenous peroxidase
activity, and then a blocking agent (1.5 % goat or rabbit
serum in PBS) was included for 5 min at 40 °C. AAA tissue
sections were incubated (30 min at 40 °C) with the
following antibodies: alpha(α)-actin (Abcam cat#5694
rabbit, 1.4 μg/mL), Ly-6G/-6C (NIMP-R14 rat, neutrophil
marker) (Abcam, cat#2557 rat, 5 μg/mL), striatin (index of
E2 receptor signaling; EMD Millipore, cat#AB5779 rabbit,
5 μg/mL), or ER-TR7 (fibroblast marker; Abcam cat#51824
rat, 2 μg/mL). Sections were washed and then a secondary
antibody (biotinylated anti-rabbit; BA-1000, Vector Labs,
7.5 μg/mL), biotinylated anti-rat (BA-4001, Vector Labs,
2.5 μg/mL), was incubated for 30 min at 40 °C. Tissue
sections were washed, incubated with Vectastain and
rinsed to detect peroxidase activity using an AEC chroma-
gen substrate. Sections were counterstained with
hematoxylin unless utilized for image quantification. Image
quantification of α-actin and striatin were done using the
hue, saturation, and intensity (HSI) method with ImagePro
Plus v.7 [13]. Briefly, sham sections (200× magnification)
were utilized to set up the baseline measurements for HSI.
Next, a mask was created for each image and an area
was boxed for each section. For α-actin, the region of
interest was the thrombus region within the medial break
of the AAA. For striatin, the region of interest was the
medial smooth muscle layer of the abdominal aorta. Neu-
trophil counts were performed in areas of aneurysm med-
ial break in a blinded fashion. At least 5–6 sections were
quantified per mouse with N = 3 mice per group.
Quantification of atherosclerosis
After quantification of external diameters of AAAs,
aortas were cut open and pinned to quantify atherosclerosis
in the aortic arch. Arch areas were defined by drawing
a 3-mm line from the left subclavian artery and every
lesion within this area was summed and divided by
the total arch area to calculate the percent lesion area [16].
Primary abdominal aorta-derived smooth muscle cell
(SMC) isolation and culture
Primary abdominal aorta-derived SMC were isolated
from C57BL/6 female mice (6–8 weeks of age) using
collagenase/elastase with soybean trypsin inhibitor diges-
tion (1 mg/mL collagenase, cat#LS004174, 0.744 units/
mL elastase, cat#LS002279, 1 mg/mL soybean trypsin
inhibitor, cat#LS003570, Worthington) of the suprarenal
and infrarenal aorta [5]. Abdominal aortic SMC were
grown in DMEM/F12 media without phenol red with
2 % penicillin/streptomycin, 1 % fungizone (Invitrogen),
and 20 % female bovine serum (Tissue Biologics) until
cells were confluent, and then trypsinized (0.25 %). All
studies in SMCs were performed on cells from passage
3–10. Cells past passage 3 were grown in 10 % female
bovine serum in culture media.
Real-time PCR (RT-PCR)
Cells were grown in six-well plates at a density of
5 × 105 cells/mL in 1 % charcoal-stripped FBS media
(Invitrogen) for 24 h prior to the start of each experi-
ment. Cells were incubated with vehicle (dimethyl
sulfoxide, DMSO, final 0.1 %) or E2 (0, 1, 10, 50, or
100 nM) for 48 h. RNA was extracted from cells
using the Promega SV Total RNA Isolation System
for Tissues and reverse transcribed (0.2 μg) using the
Quanta qScript cDNA supermix (Quanta Biosciences).
cDNA was diluted (1:10) and amplified using the Per-
fecta SYBR Green FastMix (Quanta Biosciences).
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Groups were normalized to vehicle using the delta
delta Ct method (ddCt). Glyceraldehyde phosphate
dehydrogenase (GAPDH) mRNA abundance was used
to control for DNA template concentrations. Primers
for proliferating cell nuclear antigen (PCNA) [17], for-
ward 5′-CTAGCCATGGGCGTGAAC-3′ reverse 5′-
GAATACTAGTGCTAAGGTGTCTGCAT-3′ and GAP
DH, forward 5′-GCCAAAAGGGTCATCATCTC-3′
reverse 5′-GGCCATCCACAGTCTTCT-3′ were uti-
lized for this study.
SMC proliferation assay
Abdominal aortic SMCs were cultured in 12-well plates
and seeded at a density of 1 × 104 cells/mL for 48 h in 1 %
charcoal-stripped FBS plus complete media. After wash-
ing, cells were incubated with vehicle (DMSO, final
0.1 %) or E2 (1–100 nM) for 48 h. Cells were harvested
and a fluorescent-based assay (CyQUANT, Invitrogen)
was used to quantify nucleic acid concentrations. A
standard curve was generated using thoracic or abdom-
inal cells at a starting concentration of 1 × 106 cells/mL.
Detection was based on an excitation of 480 nm and an
emission of 520 nm.
Western blot analyses
Abdominal aortic SMCs were incubated in six-well
plates with vehicle (DMSO, final 0.1 %) or E2 (1–100 nM)
for 48 h prior to protein extraction. Extraction was
performed with M-PER with protease (Roche-Mini
tablets) and phosphatase inhibitors (Thermo Fisher
phosphatase inhibitor tablets; 200 μL per well) and
samples were sonicated for 10 s on a setting of 10
(Misonix, XL-2000) and then incubated on ice for
30 min. Cell extracts were centrifuged (10,000g′s) for
10 min to pellet cellular debris, and protein concen-
tration was quantified in supernatants (BCA assay;
ThermoFischer). For Western analyses, protein
(12 μg) was electrophoresed on a 12 % reducing SDS-
PAGE gel. Antibodies utilized for Western analyses
were α-actin (Abcam, cat#5694), β-actin (Sigma
mouse, cat#A5441), SM22α/transgelin (Abcam rabbit,
cat#14106), and TGF-β (Abcam rabbit, cat#66043;
which recognizes all three isoforms of TGF-β). Pro-
tein content was quantified using background subtrac-
tion (50 pixels per blot subtracted) followed by the
gel plug-in for ImageJ 1.48v and was normalized to
GAPDH (Sigma mouse, cat#G9295).
Wound healing assay
Abdominal aortic SMCs were grown in ibidi μ-Dishes
(ibidi, Inc.) at a cell density of 5 × 105 cells/mL. After 21–
24 h, inserts were removed with sterile forceps and incu-
bated with 3 % charcoal-stripped serummedia containing
either vehicle (DMSO, final 0.1 %) or E2 (100 nM). Phase-
contrast images were taken at time 0 and 21–24 h under
40× magnification. Image analyses on areas that were not
occupied by cells were summed and data were averaged
(Nikon Elements v3.2).
Quantification of plasma and serum components
Serum E2 concentrations were quantified with a rat/
mouse serum estrogen ELISA (cat#ES180S-100, Calbio-
tech, sensitivity of the assay = 3 pg/ml). Cholesterol was
quantified in sera using an enzymatic, colorimetric kit for
esterified serum cholesterol (WAKO, cat#439-17501).
Fast performance liquid chromatography (FPLC, BioRad)
was utilized to separate lipoprotein particles using 50 μLs
of serum from each mouse (N = 3–4 mice per group). In
order to analyze areas under the curve for each FPLC,
software was utilized (PeakFit v4.12) to determine chylo-
micron (CM) CM/very-low-density lipoprotein (VLDL),
intermediate and low-density lipoprotein (LDL), and
high-density lipoprotein (HDL) areas, and cholesterol
concentrations (mg/dl) were determined from each area
[18]. Plasma renin concentrations (PRC) were quantified
by measuring angiotensin I generation in the presence of
an excess of exogenous angiotensinogen. Plasma was har-
vested from mice in ice-cold EDTA (0.2 M). Mouse
plasma (8 μl) was incubated in buffer (Na2HPO4, 0.1 M;
EDTA, 0.02 M; maleate buffer, pH 6.5; total volume of
250 μl) containing phenylmethylsulfonyl fluoride (2 /
250 μl reaction volume) for 30 min at 37 °C in a shaking
water bath. Plasma samples were incubated with an ex-
cess of exogenous rat angiotensinogen (partially purified
from nephrectomized rat plasma). The reaction was
terminated by placing samples at 100 °C for 5 min. Angio-
tensin I was quantified by radioimmunoassay using a
commercial kit (DiaSorin, cat# CA-1553).
Statistics
All in vitro studies were performed in duplicates or trip-
licates with at least three or more replicates per assay.
Aortic lumen diameters were analyzed using a linear
mixed model to compare time as a within group factor
and E2 and sham/Ovx as between group factors. Max-
imal external aortic AAA diameters were analyzed using
a one-way ANOVA. Quantification of immunostaining
for α-actin in AAA tissue sections was analyzed by one-
way ANOVA with Holms-Sidak post hoc analysis. Mea-
surements in cultured abdominal aortic VSMC incu-
bated with E2 were analyzed by one-way ANOVA with
Holms-Sidak post hoc analysis. A t test was used for
statistical analysis of wound healing results. All data
were plotted and analyzed by SigmaPlot v.12.3. Statis-
tical significance was defined as P < 0.05. Data are repre-
sented as mean ± SEM.
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Results
Effects of ovariectomy, with and without E2
administration, on characteristics of female mice
Ovariectomy (with or without E2 administration) had
no significant effect on body weight at termination of
AngII-infused females (Table 1; P > 0.05). Moreover,
plasma renin concentrations were not significantly
different between groups (Table 1; P > 0.05). E2 adminis-
tration to Ovx females significantly increased serum E2
concentrations (Table 1; P < 0.05). Blood neutrophil and
white blood cell content were decreased significantly
by E2 administration in Ovx females compared to ve-
hicle-infused controls (Table 1; P < 0.05). Other blood cells
(monocytes, platelets, basophils, eosinophils, red blood
cells) were not significantly altered by ovariectomy or by
E2 administration (data not shown).
E2 administration blunted progression of AngII-induced
AAAs in Ovx females
Females administered testosterone as neonates exhibited
AAA formation, as indicated by a significant increase in
aortic lumen diameters from day 0–28 of AngII infusions
(Fig. 1a). AAAs of equivalent sizes were stratified to each
treatment group, such that at day 28 of AngII infusions
aortic lumen, diameters did not significantly differ
between groups. Aortic lumen diameters increased pro-
gressively from day 28–70 with continued AngII infusions
in sham-operated and Ovx females administered vehicle,
with significant increases in lumen diameter (compared to
day 28) on day 60 and 70 for sham-operated and Ovx,
vehicle females (Fig. 1a; *P < 0.05). In contrast, aortic
lumen diameters of Ovx females administered E2 did
not increase significantly with continued AngII infusions
(compared to day 28). On day 70 of AngII infusions, aortic
lumen diameters of Ovx females administered E2 were
decreased significantly compared to Ovx, vehicle and
sham-operated females (Fig. 1a; #P < 0.05). Analysis of
maximal AAA diameters demonstrated a significant
overall difference between groups (P = 0.018). AAA diame-
ters were increased modestly in Ovx females administered
vehicle compared to sham-operated controls (Fig. 1b;
P = 0.087) and were decreased significantly by E2 admin-
istration compared to Ovx females administered vehicle
(*P = 0.001). Representative AAAs from each group are
illustrated in Fig. 1c. The incidence of aortic rupture was
not significantly different between groups (chi-square,
P = 0.834).
AAAs from Ovx females administered E2 have increased
smooth muscle α-actin, reduced neutrophil content, and
increased striatin immunostaining
AAAs tissue sections from Ovx females administered
vehicle exhibited reduced α-actin immunostaining
compared to sham-operated controls (Fig. 2a left and
Additional file 1: Figure S1). Quantification of α-actin
immunostaining in AAA tissue sections demonstrated
significant reductions in Ovx females administered vehicle
compared to sham-operated controls (Fig. 2b and
Additional file 1: Figure S1; P < 0.05). Administration of
E2 to Ovx females resulted in restoration of α-actin
immunostaining (Fig. 2a and Additional file 1: Figure S1)
to levels that were not significantly different from
sham-operated controls (Fig. 2b and Additional file 1:
Figure S1). We quantified neutrophil cell counts in
AAA tissue sections from mice of each group (Fig. 2a
middle, and Additional file 1: Figure S1), with a significant
twofold increase in neutrophil cell counts in Ovx females
administered vehicle compared to sham-operated fe-
males, which were restored to control levels in Ovx
females administered E2 (Fig. 2c and Additional file 1:
Figure S1; P < 0.05). As an index of estrogen receptor
signaling [17, 19], we quantified striatin immunostaining
in AAA tissue sections from mice of each group. Striatin
immunostaining was decreased markedly in AAA sec-
tions from Ovx females administered vehicle com-
pared to sham-operated controls (Fig. 2a right and
Additional file 1: Figure S1). Administration of E2 to
Ovx females increased significantly striatin immuno-
staining in AAA sections to levels that were not
different from sham-operated controls (Fig. 2d and
Additional file 1: Figure S1; P < 0.05). Fibroblasts have
been implicated in collagen production and arterial
wall remodeling. Therefore, we immunostained for
reticular fibroblasts which localized to areas of medial
breaks (black arrows, Additional file 1: Figure S2) in AAA
sections from mice in each group.
Abdominal aortic SMC respond to E2 with increased
α-actin and TGF-β and exhibit more rapid wound healing
To define mechanisms for protective effects of E2 on
AAA progression, we examined concentration-dependent
effects of E2 on abdominal aortic SMC proliferation, on
proteins associated with AAA development, and on
wound healing as an index of cell repair. Incubation of
SMC with E2 had no significant effect on proliferation
Table 1 Body weights, concentrations of plasma renin (PRC),
serum E2 and cholesterol, and blood neutrophil and white cell
content
Sham Ovx (VEH) Ovx (E2)
Body weight (g) 26.2 ± 1.9 25.6 ± 2.1 26.6 ± 1.5
PRC (ng/mL) 0.9 ± 0.1 1.0 ±0.2 0.9 ± 0.1
Serum E2 (pg/mL) 5.7 ± 0.6 4.9 ± 0.4 6.9 ± 0.6*
Serum cholesterol (mg/dl) 2222 ± 201 1875 ± 192 1373 ± 114†
Blood neutrophils (K/μL) 1.5 ± 0.1 1.7 ± 0.1 1.1 ± 0.1*
White blood cells (K/μL) 4.2 ± 0.9 5.1 ± 0.7 2.7 ± 0.4*
*P < 0.05 Ovx (VEH) vs Ovx (E2); †P < 0.05 sham vs Ovx (E2)
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(as quantified by cell number and PCNA mRNA abun-
dance) (Additional file 1: Figure S3; P > 0.05). However, E2
resulted in a concentration-dependent increase in expres-
sion of α- and β-actin (Fig. 3a; P < 0.05). Similarly, TGF-β
expression was increased significantly by E2 (100 nM;
Fig. 3b; P < 0.05). Since TGF-β promotes wound healing
[20], a wound healing assay was performed on abdominal
aortic SMCs in the absence and presence of E2. In this
assay, the area unoccupied by cells 24 hours after intro-
duction of a wound was decreased significantly by E2
(Fig. 4a, b; P < 0.05).
E2 administration significantly reduced AngII-induced
atherosclerosis in Ovx females
After 3 months of AngII infusions, the mean percent
surface area of the intima of aortic arches covered by
atherosclerotic lesions in sham-operated females was
extensive (49.5 %). Ovariectomy of female mice (vehicle
group) did not significantly alter atherosclerosis in aortic
arches (Fig. 5; P > 0.05). However, E2 administration re-
sulted in a significant decrease in atherosclerosis in Ovx
females compared to sham-operated controls (Fig. 5;
P < 0.05). Total sera cholesterol concentrations were
decreased significantly by E2 administration in Ovx females
compared to sham-operated controls (Table 1; P < 0.05).
Concentrations of chylomicrons (CM) and VLDL
cholesterol were decreased significantly in Ovx vehicle and
Ovx females administered E2 compared to sham-operated
controls (Additional file 1: Figure S4A, B; P < 0.05).
Discussion
Results from these studies demonstrate that E2 administra-
tion to Ovx female mice reduced the progression and sever-
ity of AngII-induced AAAs. AAA tissue sections from Ovx
females exhibited reduced content of SMC and fibroblast
α-actin, increased neutrophil cell counts, and reduced
striatin content. These characteristics of AAAs from Ovx
females were reversed by E2. In abdominal aortic SMC/
fibroblast, E2 incubation resulted in increased content
of α-actin and TGF-β, and augmented in vitro wound
healing. Moreover, E2 administration significantly reduced
atherosclerosis, accompanied by reductions in serum chol-
esterol concentrations. These results suggest that E2 is pro-
tective against the progression of established AngII-induced
AAAs in female mice. As the majority of females exhibiting
an AAA are post-menopausal, these results suggest that E2
administration to post-menopausal females may provide
protection against AAA progression.
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Depending on the experimental model and methods
of manipulating E2, results are conflicting regarding a
role for endogenous versus exogenous E2 in the regu-
lation of AAA formation. In female apolipoprotein E
(ApoE−/−)-deficient mice exhibiting a low susceptibility to
AngII-induced AAAs, Ovx had no significant effect on
AAA formation [3]. However, administration of exogenous
E2 (0.25 mg by pellet) [21] to male ApoE−/− mice reduced
the incidence and size of AngII-induced AAAs. In the
intra-aortic elastase model of aortic dilation exhibiting
gender differences [22], administration of E2 (0.1 mg
pellet, resulting in a threefold increase in serum E2
concentrations) decreased aneurysm size. Taken together,
these results suggest that while endogenous E2 may
not have a major impact on AAA formation, administra-
tion of exogenous E2 (to males) protects against the
formation of AAAs.
Our studies are the first to examine the progression of
established AAAs in females. While AAA formation is
markedly lower in females (experimental and human),
studies suggest that AAA progression is more rapid in
females compared to males and that AAAs rupture at
N
eu
tr
o
p
h
ils
 a
t 
m
ed
ia
l b
re
ak
 (
ce
ll 
co
u
n
t)
0
10
20
30
40
50
Sham OVX + VEH OVX + E2
*
#
Sham
OVX + VEH
OVX + E2
α-actin Neutrophils StriatinA
A
lp
h
a-
ac
ti
n
 p
er
 a
re
a 
(m
ic
ro
n
s2
)
S
tr
ia
ti
n
 p
er
 a
re
a 
(m
ic
ro
n
s2
)
0
200
400
600
800
*
Sham OVX + VEH OVX + E2
#
B C
0
200
400
600
800
Sham OVX + VEH OVX + E2
*
#
D
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smaller sizes in females [7, 9, 11, 12]. We induced AAAs
in female mice through transient neonatal exposures to
testosterone, which we reported previously to increase
adult susceptibility to AngII-induced AAAs [5]. Using
this model, our results demonstrate that exogenous E2
administration to Ovx females prevented progression
and reduced severity of AngII-induced AAAs. Similar to
our previous observation of a lack of effect of ovariectomy
to augment formation of AngII-induced AAAs [3], we did
not find a significant effect of ovariectomy to augment
progression of established AngII-induced AAAs in
females. However, AAA tissue sections from Ovx females
exhibited changes indicative of reduced smooth muscle
α-actin and increased neutrophil content, suggesting
that while aortic lumen and AAA diameters were not
significantly altered by Ovx, cellular characteristics of
AAAs were influenced by lack of endogenous E2.
Notably, these effects, in addition to other indices of
AAA growth (e.g., internal aortic lumen diameters),
were reversed or reduced by exogenous E2 administration
in Ovx females. It is possible that effects of exogenous E2
resulted from pharmacologic rather than physiologic
concentrations of E2 in females. However, marked re-
ductions in striatin immunostaining in AAA sections
in Ovx females compared to sham-operated controls,
indicative of E2 signaling, were reversed by exogenous E2
administration. Taken together, these results suggest that
both endogenous and exogenous E2 have favorable effects
on AAA progression in females.
We used abdominal aortic SMC to examine potential
mechanisms for E2’s effects to blunt progression of
AngII-induced AAAs in females. SMCs express ERα
[23], ERβ [24], and G-protein-coupled estrogen receptor
1 (GPER/GPR30) [25] that are known to bind E2.
Results of E2-mediated stimulation of α-actin in abdominal
aortic SMC in this study are consistent with previous
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observations [26, 27]. We did not define the receptor-
mediating effects of E2 to promote SMC α-actin. However,
previous studies suggest that GPR30, a membrane bound
estrogen receptor, is capable of increasing α-actin expres-
sion in smooth muscle cells [28]. Ligands to this receptor
have been examined as a potential mechanism to preserve
protective effects of E2, while avoiding sex hormone-related
side effects. Future studies should evaluate the utility of
agonists for GPR30 in protection against the formation
and progression of AAAs.
A divergent role for TGF-β has been described in
aneurysms depending on their regional location within
the aorta, with negative influences of TGF-β in aneurysms
within the aortic arch that are related to excessive AngII
activation [29], while protective effects of TGF-β have
been demonstrated in AngII-induced AAAs and xenograft
implanted aneurysm models [30, 31]. With regards to
sex hormones, testosterone has been shown to have a
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negative effect on TGF-β expression in abdominal SMCs
[13]. Conversely, previous findings have demonstrated
E2-mediated increases of TGF-β protein in prostate
SMC [32]. Our results support an effect of E2 to promote
TGF-β expression in abdominal aortic SMCs. It is well
known that TGF-β plays a pivotal role in wound healing
[20]. Moreover, we found that E2 promoted wound healing
of abdominal aortic SMC, which is consistent with previous
findings related to E2 promotion of wound healing in
several different experimental models [33, 34]. Taken
together, these results suggest that E2-mediated pro-
motion of wound healing in abdominal aortic SMC
may be TGF-β-mediated. Future studies should define
whether E2-mediated stimulation of TGF-β contributes to
protection against the progression of AngII-induced AAAs.
Results from this study also demonstrate a protective
role for exogenous E2 to reduce chronic AngII-induced
atherosclerosis in Ovx female LDL-receptor-deficient
mice. In contrast to previous findings from studies
demonstrating that ovariectomy augments diet-induced
atherosclerosis [3], our results do not support an effect
of ovariectomy to augment atherosclerosis induced by
chronic infusion of AngII. However, it is possible that
the level of atherosclerosis in AngII-infused females fed
with a Western diet was so extensive (50 % of the
intimal surface covered by lesions) that we could not
quantify a detectable increase in atherosclerosis in Ovx
females. In contrast, E2 administration significantly
reduced atherosclerosis in Ovx females, and this effect
was associated with reductions in serum cholesterol
concentrations. In women, apolipoprotein B-containing
particles are reduced when endogenous blood E2 levels
are high [35]. In agreement, our results suggest that
E2-mediated reductions in serum VLDL cholesterol
concentrations may have contributed to reductions in
atherosclerosis in Ovx females.
Conclusions
Results from this study demonstrate that exogenous E2
administration to Ovx females decreases progression of
established AngII-induced AAAs. While ovariectomy of
female mice had no significant effect on aortic lumen or
external AAA diameters, AAA tissue sections from Ovx
females exhibited tissue remodeling that was reversed by
E2 administration. In abdominal aortic SMC, E2 promoted
expression of α- and β-actin, TGF-β, and stimulated
wound healing, potential beneficial mechanisms contribut-
ing to protective effects of exogenous E2 to blunt AAA
progression. Exogenous E2 administration to Ovx females
also lowered AngII-induced atherosclerosis associated with
reductions in serum cholesterol concentrations. These
results suggest that E2 administration may protect
against more rapid AAA expansion and severity in
post-menopausal females exhibiting an AAA.
Additional file
Additional file 1: Figure S1. Alpha-actin (A), neutrophils (B), and striatin
(C) immunostaining for sham, OVX + vehicle, and OVX + E2 groups in
AAA progression study, respectively. Upper panels were taken at a low
magnification (40×, scale bar is 200 μm). Lower panels (black boxes in
upper panels) were taken at a 100× magnification to indicate where regions
of analysis were performed. Alpha-actin and neutrophil quantifications
were done in areas of the medial break and thrombus, while striatin
quantification was done on the medial smooth muscle layer of the
abdominal aorta. Note that the size of the AAA is dramatically lower
in the OVX + E2 group when compared to the OVX + vehicle group.
Figure S2. ER-T7 (fibroblast) immunostaining of sham, OVX + vehicle, and
OVX + E2 groups in AAA progression study. Upper panels represent low
magnification (40×) of each group (scale bar is 200 μm). Lower panels
(black boxes indicate where images were taken) depict where fibroblasts
were located (black arrows, 100× magnification). Figure S3. E2 did not
stimulate cell proliferation or PCNA abundance in abdominal aortic SMCs. A
Cell counts of abdominal aorta-derived SMCs with incubation of increasing
concentrations of E2 (0–100 nM). B PCNA abundance with incubation of
increasing concentrations of E2 (0–100 nM). Data were analyzed by
one-way ANOVA with comparison to vehicle (0 nM). Figure S4. Lipoprotein
profiles of sham, Ovx + vehicle (VEH), and Ovx + E2 (E2) groups. A is the
lipoprotein profiles of mice in SHAM, VEH, and E2 administration groups.
Lines above the curves represent chylomicron (CM) and very-low density
lipoprotein (VLDL) fractions, intermediate and low-density lipoprotein
fractions (I/LDL), and high-density lipoprotein fractions (HDL). B represents
the areas under the curve for the different fractions where cholesterol levels
were summed and averaged for the three treatment groups. Data were
analyzed by one-way ANOVA. Asterisks represent a significant difference
between sham and other groups (P < 0.05).
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